Regardless of First skepticism, new advancements in peptide drug discovery have rejuvenated interest in peptides as therapeutic agents, with about 70 peptides currently marketed and several Other individuals in clinical development. Any potential conflicts of fascination, including funding from pharmaceutical companies or particular investments